ADVOCATE is a new ARPA-H funding opportunity focused on transforming cardiovascular care through agentic clinical AI. The Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE) program seeks teams from industry, academia, nonprofits, and small businesses to develop trusted, FDA-authorized AI agents that can provide continuous, autonomous cardiovascular care, while being safely monitored by a supervisory AI system after deployment.

A Solution Summary is due February 27, 2026, with Full Proposals due April 1, 2026 for teams encouraged to proceed. For more details, click here.